Readiness to Change and Prospective Effects of Weight Management Programs in Pediatric Nonalcoholic Fatty Liver Disease

被引:3
|
作者
Slowik, Voytek [1 ]
Wasserkrug, Heather [1 ]
Fischer, Ryan T. [1 ]
Connelly, Mark [2 ]
Deacy, Amanda D. [1 ,2 ]
Hampl, Sarah [3 ,4 ]
Daniel, James F. [1 ]
机构
[1] Univ Missouri, Div Pediat Gastroenterol, Childrens Mercy Kansas City, Kansas City Sch Med, Kansas City, MO USA
[2] Univ Missouri, Div Dev & Behav Hlth, Childrens Mercy Kansas City, Kansas City Sch Med, Kansas City, MO USA
[3] Univ Missouri, Div Gen Acad Pediat, Childrens Mercy Kansas City, Kansas City Sch Med, Kansas City, MO USA
[4] Univ Missouri, Ctr Childrens Hlth Lifestyles & Nutr, Childrens Mercy Kansas City, Kansas City Sch Med, Kansas City, MO USA
来源
CTS-CLINICAL AND TRANSLATIONAL SCIENCE | 2021年 / 14卷 / 02期
关键词
OF-THE-LITERATURE; ADOLESCENT OVERWEIGHT; OBESITY; INTERVENTION; CHILDREN; OUTCOMES; MOTIVATION; ATTENDANCE; RISK;
D O I
10.1111/cts.12913
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is an increasing problem in pediatrics with limited treatment options. We prospectively assessed outcomes in patients managed in a hepatology clinic (HC) alone vs. those managed in combination with a multidisciplinary weight management program (MWMP). We describe each group's readiness to change at the time of NAFLD diagnosis. Patients diagnosed with NAFLD were given a modified Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) at enrollment (T1) to assess readiness to change. They were then followed at 3-9 months (T2) and at 10-15 months (T3). Linear mixed models were used to evaluate changes in body mass index (BMI), BMI z-score, and transaminases over time and between the two groups. There were no significant treatment group main effects or treatment x time interactions for our primary end points for HC alone (n = 75) or with MWMP (n = 18). There was a significant main effect for time for BMI z-score, with BMI z-scores declining on average by 0.0568 (P = 0.004) from visit to visit. Low SOCRATES subscales scores in HC alone (n = 33) or with MWMP (n = 4) suggested a patient population with low recognition of disease and likelihood of taking steps for change. Patients with obesity and NAFLD had low scores on all three SOCRATES subscales. Despite this, both groups had improvement in BMI z-score without significant difference between the two treatment groups in other primary end points. Further study is needed to identify the most effective patient selection and treatment strategies for pediatric patients with NAFLD, including pharmacotherapy and surgery.
引用
收藏
页码:582 / 588
页数:7
相关论文
共 50 条
  • [21] Nonalcoholic Fatty Liver Disease Pathophysiology and Management
    Carr, Rotonya M.
    Oranu, Amanke
    Khungar, Vandana
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2016, 45 (04) : 639 - +
  • [22] Nonalcoholic Fatty Liver Disease: Diagnosis and Management
    Wilkins, Thad
    Tadkod, Altaf
    Hepburn, Iryna
    Schade, Robert R.
    AMERICAN FAMILY PHYSICIAN, 2013, 88 (01) : 35 - 42
  • [23] Current Concepts in Pediatric Nonalcoholic Fatty Liver Disease
    Fleet, Sarah E.
    Lefkowitch, Jay H.
    Lavine, Joel E.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2017, 46 (02) : 217 - +
  • [24] Approach to Pediatric Obesity and Nonalcoholic Fatty Liver Disease
    Bartlett, Johanna M. Ascher
    Mittal, Naveen
    PEDIATRIC ANNALS, 2021, 50 (11): : E474 - E477
  • [25] Psychotropic Medications Are Associated With Increased Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease
    Mouzaki, Marialena
    Yodoshi, Toshifumi
    Arce-Clachar, Ana C.
    Bramlage, Kristin
    Fei, Lin
    Ley, Sanita L.
    Xanthakos, Stavra A.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2019, 69 (03) : 339 - 343
  • [26] Treating Pediatric Nonalcoholic Fatty Liver Disease with Cysteamine: Is Adiponectin the Key?
    Xanthakos, Stavra A.
    Kohli, Rohit
    JOURNAL OF PEDIATRICS, 2012, 161 (04) : 579 - 581
  • [27] Nonalcoholic Fatty Liver Disease
    Isaacs, Scott
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (01) : 149 - 164
  • [28] Nonalcoholic Fatty Liver Disease After Liver Transplantation for Cryptogenic Cirrhosis or Nonalcoholic Fatty Liver Disease
    Yalamanchili, Kanthi
    Saadeh, Sherif
    Klintmalm, Goeran B.
    Jennings, Linda W.
    Davis, Gary L.
    LIVER TRANSPLANTATION, 2010, 16 (04) : 431 - 439
  • [29] Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy
    Friesen, Chance S.
    Hosey-Cojocari, Chelsea
    Chan, Sherwin S.
    Csanaky, Ivan L.
    Wagner, Jonathan B.
    Sweeney, Brooke R.
    Friesen, Alec
    Fraser, Jason D.
    Shakhnovich, Valentina
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [30] Hedgehog Pathway and Pediatric Nonalcoholic Fatty Liver Disease
    Swiderska-Syn, Marzena
    Suzuki, Ayako
    Guy, Cynthia D.
    Schwimmer, Jeffrey B.
    Abdelmalek, Manal F.
    Lavine, Joel E.
    Diehl, Anna Mae
    HEPATOLOGY, 2013, 57 (05) : 1814 - 1825